TSXV:LOVE (Canada)  
Cannara Biotech Inc logo

Cannara Biotech Inc

C$ 0.10 (0%) Nov 29
P/E:
At Loss
P/B:
1.37
Market Cap:
C$ 87.75M ($ 64.94M)
Enterprise V:
C$ 115.16M ($ 85.22M)
Volume:
29.32K
Avg Vol (2M):
88.42K
Also Trade In:
Volume:
29.32K
Market Cap C$:
87.75M
Market Cap $:
64.94M
PE Ratio:
At Loss
Avg Vol (2-Month):
88.42K
Enterprise Value C$:
115.16M
Enterprise Value $:
85.22M
PB Ratio:
1.37
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. The company owns two mega Quebec-based facilities. Leveraging Quebec's low electricity and labor rates, Cannara's facilities produce handcrafted premium-quality cannabis at affordable prices.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.12
Equity-to-Asset 0.6
Debt-to-Equity 0.49
Debt-to-EBITDA 5.17
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.36
Distress
Grey
Safe
Beneish M-Score -0.67
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 78.24
9-Day RSI 54.3
14-Day RSI 46.18
12-1 Month Momentum % -12

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.13
Quick Ratio 0.97
Cash Ratio 0.34
Days Inventory 174.94
Days Sales Outstanding 41.75
Days Payable 107.78

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.1

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 38.7
Operating Margin % -0.61
Net Margin % 2.92
ROE % 1.52
ROA % 0.96
ROIC % -0.24
ROC (Joel Greenblatt) % 3.24
ROCE % 2.94

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 3.03
PB Ratio 1.37
Price-to-Tangible-Book 1.43
EV-to-EBIT 46.47
EV-to-EBITDA 19.01
EV-to-Revenue 3.8
EV-to-FCF -2.74
Earnings Yield (Greenblatt) % 2.15

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 30.286
EPS (TTM) (C$) -0.01
Beta 1.52
Volatility % 34.83
14-Day RSI 46.18
14-Day ATR (C$) 0.00468
20-Day SMA (C$) 0.09925
12-1 Month Momentum % -12
52-Week Range (C$) 0.095 - 0.15
Shares Outstanding (Mil) 877.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cannara Biotech Inc Filings

Document Form Filing Date
No Filing Data

Cannara Biotech Inc Analysis

Share your research